Although BRG1 expression is found to be upregulated in the vast majority of human HCC samples, it is worth to note that a small percentage of HCCs have low expression of BRG1 or harbor inactivating SMARCA4 mutations, suggesting a possible tumor suppressor role of BRG1. Here, SMARCA4 is linked to neoplasm.